Last reviewed · How we verify
pregabalin capsules — Competitive Intelligence Brief
marketed
Gabapentinoid; anticonvulsant; anxiolytic
Alpha-2-delta-1 subunit of voltage-gated calcium channels
Neurology; Pain Management; Psychiatry
Small molecule
Live · refreshed every 30 min
Target snapshot
pregabalin capsules (pregabalin capsules) — AstraZeneca. Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| pregabalin capsules TARGET | pregabalin capsules | AstraZeneca | marketed | Gabapentinoid; anticonvulsant; anxiolytic | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Gabapentin Capsules | Gabapentin Capsules | EpiCept Corporation | marketed | Anticonvulsant; Gabapentinoid | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Standard dose gabapentin | Standard dose gabapentin | Mario Negri Institute for Pharmacological Research | marketed | Anticonvulsant; gabapentinoid | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Placebo matched with pregabalin | Placebo matched with pregabalin | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | phase 3 | Gabapentinoid | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Perioperative Pregabalin | Perioperative Pregabalin | McMaster University | phase 3 | Gabapentinoid; anticonvulsant; anxiolytic analgesic | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Pregabalin add-on therapy | Pregabalin add-on therapy | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | phase 3 | Gabapentinoid | Alpha-2-delta-1 subunit of voltage-gated calcium channels | |
| Neurontin | gabapentin | Generic (originally Parke-Davis/Pfizer) | marketed | Gabapentinoid (anticonvulsant/neuropathic pain agent) | Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor | 1993-12-30 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Gabapentinoid; anticonvulsant; anxiolytic class)
- AstraZeneca · 1 drug in this class
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
- Hawler Medical University · 1 drug in this class
- Jiangsu HengRui Medicine Co., Ltd. · 1 drug in this class
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- pregabalin capsules CI watch — RSS
- pregabalin capsules CI watch — Atom
- pregabalin capsules CI watch — JSON
- pregabalin capsules alone — RSS
- Whole Gabapentinoid; anticonvulsant; anxiolytic class — RSS
Cite this brief
Drug Landscape (2026). pregabalin capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/pregabalin-capsules. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab